Knight Therapeutics Inc. (TSX: GUD)

Knight Therapeutics Ratios and Metrics

Market cap in millions CAD. Fiscal year is January - December.

Year Ending	Current	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Market Capitalization	581	541	584	630	696	1,028
Market Cap Growth	10.65%	-7.35%	-7.29%	-9.50%	-32.33%	-6.41%
Enterprise Value	451	455	466	510	337	321
Last Close Price	5.73	5.19	5.18	5.30	5.35	7.58
PE Ratio	-	-32.44	-19.91	42.09	16.76	75.80
PS Ratio	1.81	1.65	1.99	2.59	3.49	21.66
PB Ratio	0.76	0.72	0.71	0.75	0.78	1.12
P/FCF Ratio	9.55	15.45	13.86	15.44	-39.57	229.12
P/OCF Ratio	8.58	15.05	12.97	14.11	-57.00	223.69
EV/Sales Ratio	1.36	1.39	1.59	2.10	1.69	6.75
EV/EBITDA Ratio	8.61	8.55	11.38	15.73	113.34	-354.58
EV/EBIT Ratio	132.78	71.47	-27.33	-39.78	-12.81	-69.11
EV/FCF Ratio	7.42	13.01	11.07	12.52	-19.17	71.44
Debt / Equity Ratio	0.09	0.09	0.09	0.05	0.06	0.07
Debt / EBITDA Ratio	1.34	1.24	1.73	1.18	9.99	-
Debt / FCF Ratio	1.15	1.97	1.84	1.00	-3.20	13.86
Asset Turnover	0.33	0.33	0.29	0.24	0.17	0.04
Inventory Turnover	1.84	1.90	1.89	1.99	1.85	0.57
Quick Ratio	2.47	2.35	2.08	2.16	4.28	1.50
Current Ratio	3.33	3.20	2.80	2.90	4.84	1.77
Return on Equity (ROE)	-2.21%	-2.14%	-3.58%	1.81%	3.53%	1.85%
Return on Assets (ROA)	0.21%	0.40%	-1.04%	-0.79%	-1.40%	-0.25%
Return on Capital (ROIC)	0.24%	0.46%	-1.19%	-0.88%	-1.71%	-0.29%
Earnings Yield	-2.90%	-3.11%	-5.12%	2.49%	6.05%	1.41%
FCF Yield	10.47%	6.47%	7.22%	6.48%	-2.53%	0.44%
Buyback Yield / Dilution	7.58%	6.46%	7.73%	5.65%	5.82%	2.19%
Total Shareholder Return	7.58%	6.46%	7.73%	5.65%	5.82%	2.19%

Source: S&P Capital IQ. Standard template.